NYSE:BSXMedical Equipment
Boston Scientific Trial Wins And Approvals Contrast With Recent Share Weakness
Q1 2026, Boston Scientific (NYSE:BSX) reported positive clinical trial results for the WATCHMAN FLX Left Atrial Appendage Closure Device and the EKOS Endovascular System.
The company completed its acquisition of Valencia Technologies Corporation during the quarter.
Boston Scientific also received regulatory approvals for the OPAL HDx Mapping System and the Asurys Fluid Management System.
Boston Scientific is a large medical device company focused on cardiovascular, endovascular, and other...